2020

Lesion evolution and neurodegeneration in RVCL-S: a monogenic microvasculopathy.  Ford AL, Chin V, Fellah S, Binkley MM, Bodin A, Balasetti V, Taiwo Y, Kang P, Lin D, Jen J, Grand G, Bogacki M, Liszewski K, Hourcade D, Chen Y, Hassenstab J, Lee JM, An H, Miner JJ, Atkinson JP. 

Neurology.  2020. Sep 4.


Immunopathology of Zika virus infection. Platt DJ, Miner JJ.

Adv Virus Res. 2020;107:223-246. Epub 2020 Jul 7.


STING gain-of-function disrupts lymph node organogenesis and innate lymphoid cell development in mice.  Bennion BG, Croft CA, Ai TL, Qian W, Menos AM, Miner CA, Fremond ML, Doisne JM, Andhey PS, Platt DJ, Bando JK, Wang ER, Luksch H, Molina TJ, Robison EDO, Artyomov MN, Rosen-Wolff A, Colonna M, Rieux-Laucat F, Di Santo JP, Neven B, Miner JJ.

Cell Rep.  2020. Jun 16;31(11):107771.


TBK1 and IKKe act redundantly to mediate STING-induced NF-kB responses in myeloid cells.  Balka KR, Louis C, Saunders TL, Smith AM, Calleja DJ, D’Silva DB, Moghaddas F, Tailler M, Lawlor KE, Zhan Y, Burns CJ, Wicks IP, Miner JJ, Kile BT, Masters SL, De Nardo D.

Cell Rep. 2020 Apr 7;31(1):107492.


Barrier-to-Autointegration Factor 1 protects against a basal cGAS-STING response.  Ma H, Qian W, Bambouskova M, Collins PL, Porter SI, Byrum AK, Zhang R, Artyomov M, Oltz EM, Mosammaparast N, Miner JJ, Diamond MS.

mBio. 2020 Mar 10; 11(2). pii: e00136-20.


Protective and Pathogenic Effects of Interferon Signaling During Pregnancy.  Casazza, RL, Lazear, HJ, Miner JJ. 

Viral Immunology. 2020. Jan/Feb; 33(1):3-11.


2019

A human STAT1 gain-of-function mutation impairs CD8+ T cell responses against gammaherpesvirus-68. Qian W, Miner CA, Ingle H, Platt DJ, Baldridge MT, Miner JJ.

J Virol. 2019 Sep 12;93(19). pii: e00307-19.


Viral complementation of immunodeficiency confers protection against enteric pathogens via interferon-λ. Ingle H, Lee S, Ai T, Orvedahl A, Rodgers R, Zhao G, Sullender M, Peterson ST, Locke M, Liu TC, Yokoyama CC, Sharp B, Schultz-Cherry S, Miner JJ, Baldridge MT.

Nat Microbiol. 2019 Jul;4(7):1120-1128. PMID:30936486


STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death. Wu J, Chen YJ, Dobbs N, Sakai T, Liou J, Miner JJ, Yan N.

J Exp Med. 2019 Apr 1;216(4):867-883. doi: 10.1084/jem.20182192.


STING-associated lung disease in mice relies on T cells but not type I interferon. Luksch H, Stinson WA, Platt DJ, Qian W, Kalugotla G, Miner CA, Bennion BG, Gerbaulet A, Rösen-Wolff A, Miner JJ.

J Allergy Clin Immunol. 2019 Jul; 144(1):154-266.e8.


A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice. Bennion BG, Ingle H, Ai TL, Miner CA, Platt DJ, Smith AM, Baldridge MT, Miner JJ.

J Virol. 2019 Feb 5;93(4). pii: e01806-18.


2018

Tofacitinib for refractory uveitis and scleritis. Paley MA, Karacal H, Rao PK, Margolis TP, Miner JJ.

Am J Ophthalmol Case Rep. 2018 Dec 4;13:53-55. doi: 10.1016/j.ajoc.2018.12.001. eCollection 2019 Mar.


HOIL1 Is Essential for the Induction of Type I and III Interferons by MDA5 and Regulates Persistent Murine Norovirus Infection. MacDuff DA, Baldridge MT, Qaqish AM, Nice TJ, Darbandi AD, Hartley VL, Peterson ST, Miner JJ, Iwai K, Virgin HW.

J Virol. 2018 Nov 12;92(23). pii: e01368-18. doi: 10.1128/JVI.01368-18. Print 2018 Dec 1. PMID:30209176


Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signaling. Hansen AL, Buchan GJ, Rühl M, Mukai K, Salvatore SR, Ogawa E, Andersen SD, Iversen MB, Thielke AL, Gunderstofte C, Motwani M, Møller CT, Jakobsen AS, Fitzgerald KA, Roos J, Lin R, Maier TJ, Goldbach-Mansky R, Miner CA, Qian W, Miner JJ, Rigby RE, Rehwinkel J, Jakobsen MR, Arai H, Taguchi T, Schopfer FJ, Olagnier D, Holm CK.

Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7768-E7775. doi: 10.1073/pnas.1806239115. Epub 2018 Jul 30.PMID:30061387


Flavivirus-infected human placentas on the cover of Science Translational Medicine

Zika virus-related neurotropic flaviviruses infect human placental explants and cause fetal demise in mice. Platt DJ, Smith AM, Arora N, Diamond MS, Coyne CB, Miner JJ.

Sci Transl Med. 2018 Jan 31;10(426). pii: eaao7090. doi: 10.1126/scitranslmed.aao7090. PMID:29386359


Editorial: Lessons Learned From Chikungunya in the Americas. Miner JJ, Lenschow DJ.

Arthritis Rheumatol. 2018 Apr;70(4):477-479. doi: 10.1002/art.40421. Epub 2018 Mar 13. No abstract available. PMID:29361204


2017

Consequences of congenital Zika virus infection. Platt DJ, Miner JJ.

Curr Opin Virol. 2017 Dec;27:1-7. doi: 10.1016/j.coviro.2017.09.005. Epub 2017 Nov 6. Review. PMID:29080429


STING-associated vasculopathy develops independently of IRF3 in mice. Warner JD, Irizarry-Caro RA, Bennion BG, Ai TL, Smith AM, Miner CA, Sakai T, Gonugunta VK, Wu J, Platt DJ, Yan N, Miner JJ.

J Exp Med. 2017 Nov 6;214(11):3279-3292. doi: 10.1084/jem.20171351. Epub 2017 Sep 26. PMID:28951494


Gestational Stage and IFN-λ Signaling Regulate ZIKV Infection In Utero. Jagger BW, Miner JJ, Cao B, Arora N, Smith AM, Kovacs A, Mysorekar IU, Coyne CB, Diamond MS.

Cell Host Microbe. 2017 Sep 13;22(3):366-376.e3. doi: 10.1016/j.chom.2017.08.012. PMID:28910635


Congenital Zika virus infection: More than just microcephaly. Miner JJ.

Sci Transl Med. 2017 Jun 7;9(393). pii: eaan8195. doi: 10.1126/scitranslmed.aan8195. PMID: 28592568


Dengue Antibodies, then Zika: A Fatal Sequence in Mice. Miner JJ, Diamond MS.

Immunity. 2017 May 16;46(5):771-773. doi: 10.1016/j.immuni.2017.04.023. PMID:28514683


Defeating Zika. Miner JJ.

Sci Transl Med. 2017 Apr 26;9(387). pii: eaan2785. doi: 10.1126/scitranslmed.aan2785. PMID:28446685


Gamete fusion gone viral. Miner JJ.

Sci Transl Med. 2017 Mar 15;9(381). pii: eaam9866. doi: 10.1126/scitranslmed.aam9866. PMID:28298425


Zika Virus Pathogenesis and Tissue Tropism. Miner JJ, Diamond MS.

Cell Host Microbe. 2017 Feb 8;21(2):134-142. doi: 10.1016/j.chom.2017.01.004. Review. PMID:28182948


Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Burt FJ, Chen W, Miner JJ, Lenschow DJ, Merits A, Schnettler E, Kohl A, Rudd PA, Taylor A, Herrero LJ, Zaid A, Ng LFP, Mahalingam S.

Lancet Infect Dis. 2017 Apr;17(4):e107-e117. doi: 10.1016/S1473-3099(16)30385-1. Epub 2017 Feb 1. Review. PMID:28159534


Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis. Miner JJ, Cook LE, Hong JP, Smith AM, Richner JM, Shimak RM, Young AR, Monte K, Poddar S, Crowe JE Jr, Lenschow DJ, Diamond MS.

Sci Transl Med. 2017 Feb 1;9(375). pii: eaah3438. doi: 10.1126/scitranslmed.aah3438. PMID: 28148840